Physician

Michael John Dragun, MD

According to 2025 Medicare claims, Michael Dragun, MD (NPI: 1679574099) practices urology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is PREMIER FAMILY CARE I, INC (NPI: 1275522864; TIN: 752656723) and primary practice location at 79701-3887. Dragun is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Dragun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 702 traditional Medicare patients, billed 3,881 HCPCS/CPT codes, and received $211,345 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,130 prescription claims across 563 beneficiaries totaling $129,795 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 296 claims. Open Payments data shows 7 records totaling $119. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $142,203 to $129,795. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $677 to $552.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	706	2,594	$171,877
2016	749	3,007	$181,334
2017	677	2,517	$147,508
2018	628	2,545	$160,993
2019	664	2,846	$189,745
2020	587	2,402	$157,376
2021	607	3,201	$210,965
2022	655	3,102	$199,277
2023	614	3,100	$193,834
2024	702	3,881	$211,345

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	386	1,541	$142,203
2016	348	1,524	$127,503
2017	351	1,522	$147,370
2018	360	1,547	$160,548
2019	420	1,924	$151,538
2020	450	1,948	$258,356
2021	524	2,131	$335,498
2022	522	2,058	$301,348
2023	465	1,896	$196,858
2024	563	2,130	$129,795

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	239	$34,437
2016	N/R	138	$18,588
2017	N/R	116	$23,013
2018	12	240	$34,177
2019	28	289	$56,924
2020	35	320	$50,868
2021	11	264	$27,661
2022	25	271	$21,608
2023	N/R	93	$22,693
2024	12	296	$42,412

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	546	891	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	192	233	$68
51798	Ultrasound measurement of bladder capacity after voiding	155	217	$8
81000	Manual urinalysis test with examination using microscope, non-automated	351	507	$4
81002	Urinalysis, manual test	371	580	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	52	2,820	$40,338
Tamsulosin Hcl	Tamsulosin Hcl	691	51,321	$9,753
Gemtesa	Vibegron	11	556	$8,733
Potassium Citrate Er	Potassium Citrate	54	4,093	$7,458
Dutasteride	Dutasteride	206	13,561	$6,034

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	27	$27,295
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	67	$12,244
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	12	47	$1,023
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	36	$668
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	N/R	35	$428

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$119	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael John Dragun, MD?

Tedicare shows public-source Medicare data for Michael John Dragun, MD (NPI 1679574099), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael John Dragun, MD have ACO affiliation data?

Michael John Dragun, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Michael John Dragun, MD?

Michael John Dragun, MD is linked to PREMIER FAMILY CARE I, INC (billing NPI 1275522864) in the available physician profile data.

Does Michael John Dragun, MD have Open Payments data?

Michael John Dragun, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.